The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
Abstract
The body cholesterol pool increases with decreasing plasma-high-density-lipoprotein (H.D.L.) but is unrelated to the plasma concentrations of total cholesterol and other lipoproteins. This finding supports existing evidence that H.D.L. facilitates the uptake of cholesterol from peripheral tissues and its transport to the liver for catabolism and excretion. Plasma-H.D.L., is reduced in several conditions associated with an increased risk of future ischaemic heart-disease (I.H.D.), namely hypercholesterolaemia, hypertriglyceridaimia, male sex, obesity, and diabetes mellitus, while subjects with existing clinical I.H.D. have lower levels of H.D.L. than healthy subjects within the same community. It is proposed that a reduction of plasma-H.D.L. concentration may accelerate the development of atherosclerosis, and hence I.H.D., by impairing the clearance of cholesterol from the arterial wall.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“there is an inverse relationship between serum HDL levels and the risk of coronary heart disease49,50.”
From Perspectives and opportunities for nanomedicine in the management of atherosclerosis (2011) · cites this paper as [49]
In the citing paper
“For many decades, a low level of HDL-C has been viewed as a robust and independent CVD risk factor1-4.”
From Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor?: New Insights From the Framingham Offspring Study (2016) · cites this paper as [1]
Citations
Cites
The plasma lecithin:cholesterol acyltransferase reaction
Glomset, J. A. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43114-1 · Cited by 2,396
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.
Kannel, W., Castelli, W., Gordon, T., & McNamara, P. M. (2020) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-1 · Cited by 2,160
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701052760107 · Cited by 1,911
ISCHÆMIC HEART-DISEASE IN RELATION TO FASTING VALUES OF PLASMA TRIGLYCERIDES AND CHOLESTEROL
Carlson, L., & Böttiger, L. E. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90738-6 · Cited by 752
PLASMA LIPID AND LIPOPROTEIN PATTERN IN GREENLANDIC WEST-COAST ESKIMOS
Bang, H. O., Dyerberg, J., & Nielsen, A. B. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91658-8 · Cited by 690
Protein-lipid relationships in human plasma
Barr, D. P., Russ, E. M., & Eder, H. A. (1951) · The American Journal of Medicine · doi:10.1016/0002-9343(51)90183-0 · Cited by 635
RISKS OF ISCHÆMIC HEART-DISEASE IN FAMILIAL HYPERLIPOPROTEINÆMIC STATES
Slack, J. (1969) · The Lancet · doi:10.1016/s0140-6736(69)90930-1 · Cited by 625
PLASMA LIPID AND LIPOPROTEIN PATTERN IN GREENLANDIC WEST-COAST ESKIMOS
Bang, H. O., Dyerberg, J., & Nielsen, A. B. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1986.tb07607.x · Cited by 604
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701192760305 · Cited by 526
VIGOROUS EXERCISE IN LEISURE-TIME AND THE INCIDENCE OF CORONARY HEART-DISEASE
Morris, J. N., Chave, S. P. W., Adam, C., Sirey, C., Epstein, L. H., & Sheehan, D. J. (1973) · The Lancet · doi:10.1016/s0140-6736(73)90128-1 · Cited by 456
Carlson, K. (1973) · Journal of Clinical Pathology · doi:10.1136/jcp.s1-5.1.32 · Cited by 420
Serum Lipids in Men with Myocardial Infarction
Carlson, L. A. (1960) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1960.tb03562.x · Cited by 325
Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia
Grundy, S. M., AHRENS, E. H., Salen, G., Schreibman, P. H., & Nestel, P. J. (1972) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39388-3 · Cited by 301
Turnover of plasma cholesterol in man
Goodman, D. S., & Noble, R. P. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105719 · Cited by 294
Metabolic relationships among the plasma lipoproteins
Wilson, D. E., & Lees, R. S. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106896 · Cited by 290
Coronary Heart Disease: Overweight and Obesity as Risk Factors
Keys, A. B., Aravanis, C., BLACKBURN, H. W., van Buchem, F. S. P., Buzina, R., DJORDJEVIC, B. S., Fidanza, F., Karvonen, M. J., Menotti, A., PUDDU, V., et al. (1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-77-1-15 · Cited by 243
Histological and immunofluorescent studies on the evolution of the human atheromatous plaque
WALTON, K. W., & Williamson, N. (1968) · Journal of Atherosclerosis Research · doi:10.1016/s0368-1319(68)80020-1 · Cited by 237
Evans, G. W., Phillips, G. E., Mukherjee, T. M., Snow, M. R., LAWRENCE, J. R., & Thomas, D. W. (1973) · Journal of Clinical Pathology · doi:10.1136/jcp.26.1.32 · Cited by 225
A comparison of heritable abnormal lipoprotein patterns as defined by two different techniques
Fredrickson, D. S., Levy, R. I., & Lindgren, F. T. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105927 · Cited by 224
Dietschy, J. M., & Wilson, J. D. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105706 · Cited by 223
Distribution and turnover of cholesterol in humans
Nestel, P. J., Whyte, H. M., & Goodman, D. S. (1969) · Journal of Clinical Investigation · doi:10.1172/jci106079 · Cited by 213
RELATIONSHIP BETWEEN LOW-DENSITY LIPOPROTEIN IN AORTIC INTIMA AND SERUM-LIPID LEVELS
Smith, E. B., & Slater, R. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90122-5 · Cited by 205
BODY CHOLESTEROL METABOLISM IN MAN. I. THE EQUILIBRATION OF SERUM AND TISSUE CHOLESTEROL*†
Chobanian, A. V., & Hollander, W. (1962) · Journal of Clinical Investigation · doi:10.1172/jci104631 · Cited by 203
Furman, R. H., Howard, R. P., LAKSHMI, K., & Norcia, L. N. (1961) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/9.1.73 · Cited by 187
Dietary and Drug Treatment of Primary Hyperlipoproteinemia
Levy, R. I., FREDRICKSON, D. S., SHULMAN, R., BILHEIMER, D. W., Breslow, J. L., STONE, N. J., LUX, S. E., SLOAN, H. R., Krauss, R. M., & HERBERT, P. N. (1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-77-2-267 · Cited by 183
Physiological Ce:Roles of Lecithin—Cholesterol Acyltransferase
Glomset, J. A. (1970) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/23.8.1129 · Cited by 183
Cholestyramine Resin Therapy for Hypercholesteremia
Hashim, S. A. (1965) · JAMA · doi:10.1001/jama.1965.03080170017004 · Cited by 171
Human Serum Lipoproteins and Their Interrelationships
Nichols, A. V. (1967) · Advances in biological and medical physics · doi:10.1016/b978-1-4832-3107-5.50008-x · Cited by 170
FREQUENCY OF RISK FACTORS FOR ISCHÆMIC HEART-DISEASE IN A HEALTHY BRITISH POPULATION
Lewis, B., Wootton, I. D. P., Krikler, D. M., February, A., Chait, A., Oakley, C. M., Sigurdsson, G., Maurer, B., & Birkhead, J. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92438-6 · Cited by 165
Carlson, L. A., & Mossfeldt, F. (1964) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1964.tb03951.x · Cited by 163
Murphy, J. R. (1962) · Journal of Laboratory and Clinical Medicine · doi:10.5555/uri:pii:0022214362900501 · Cited by 154
Cholesterol Metabolism in Human Obesity
Nestel, P. J., Schreibman, P. H., & AHRENS, E. H. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107428 · Cited by 151
The removal of cholesterol from landschütz ascites cells by high-density apolipoprotein
Stein, O. T., & Stein, Y. (1973) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(73)90249-x · Cited by 141
Factors affecting lipoprotein metabolism.
Scanu, A. M. (1965) · PubMed · Cited by 133
In vitro incorporation of cholesterol-14C in to very low density lipoprotein cholesteryl esters
Akanuma, Y., & Glomset, J. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42709-9 · Cited by 123
Strisower, E. H., Adamson, G. L., & Strisower, B. (1968) · The American Journal of Medicine · doi:10.1016/0002-9343(68)90165-4 · Cited by 110
Scanu, A. M. (1965) · Advances in lipid research · doi:10.1016/b978-1-4831-9939-9.50009-7 · Cited by 99
Jencks, W. P., Hyatt, M. R., Jetton, M. R., Mattingly, T. W., & DURRUM, E. L. (1956) · Journal of Clinical Investigation · doi:10.1172/jci103358 · Cited by 90
CHOLESTEROL FLUX IN THE ATHEROSCLEROTIC PLAQUE*
Zilversmit, D. B. (1968) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1968.tb53830.x · Cited by 83
Brunner, D., & Löbl, K. (1958) · Annals of Internal Medicine · doi:10.7326/0003-4819-49-4-732 · Cited by 79
Epidemiology of coronary heart disease. Implications for the practicing physician.
Kannel, W. B., KAGAN, A., Dawber, T. R., & Revotskie, N. (1962) · PubMed · Cited by 76
Serum cholesterol and relative body weight of coronary patients in different populations
KEYS, A., & FIDANZA, F. (1960) · Circulation · doi:10.1161/01.cir.22.6.1091 · Cited by 74
The status of risk factors and coronary heart disease
Simborg, D. W. (1970) · Journal of Chronic Diseases · doi:10.1016/0021-9681(70)90031-7 · Cited by 63
Improved estimation of body masses and turnover of cholesterol by computerized input–output analysis
Samuel, P., & Lieberman, S. (1973) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36906-6 · Cited by 63
Effects of colestipol, a new bile-acid-sequestering resin, on cholesterol metabolism in man.
Miller, N. E., Clifton-Bligh, P. B., & Nestel, P. J. (1973) · PubMed · Cited by 61
Self-citationLipoprotein lipid alterations with cholestyramine administration.
Jones, R. J., & Dobrilovic, L. (1970) · PubMed · Cited by 58
Samuel, P., & Perl, W. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106243 · Cited by 58
Nestel, P. J. (1970) · Advances in lipid research · doi:10.1016/b978-0-12-024908-4.50008-8 · Cited by 56
Long-Term Effects of Clofibrate (Atromid-S) on Serum Lipids in Man
Hunninghake, D. B., Tucker, D. R., & Azarnoff, D. L. (1969) · Circulation · doi:10.1161/01.cir.39.5.675 · Cited by 54
Samuel, P., Perl, W., Holtzman, C. M., Rochman, N. D., & Lieberman, S. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106811 · Cited by 43
Diabetes in 1964: A World Survey
Entmacher, P. S., & Marks, H. H. (1965) · Diabetes · doi:10.2337/diab.14.4.212 · Cited by 42
Day, A. J., & Wilkinson, G. K. (1967) · Circulation Research · doi:10.1161/01.res.21.5.593 · Cited by 42
The pathogenesis of atherosclerosis.
Adams, C. W. M. (1973) · Journal of Clinical Pathology · doi:10.1136/jcp.s1-5.1.38 · Cited by 40
The Efficacy of Clofibrate (CPIB) in Familial Hyperlipoproteinemias
Levy, R. I., Quarfordt, S. H., Brown, W. V., Sloan, H. R., & Fredrickson, D. S. (1969) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-6866-7_31 · Cited by 30
Hypocholesterolemic agents and mobilization of tissue cholesterol in man
Sodhi, H. S., Kudchodkar, B. J., & Horlick, L. (1973) · Atherosclerosis · doi:10.1016/0021-9150(73)90130-5 · Cited by 28
Cornwell, D. G., Kruger, F. A., Hamwi, G. J., & Brown, J. B. (1961) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/9.1.41 · Cited by 28
Plasma Lipid and Lipoprotein Levels in Childhood and Adolescence
Dyerberg, J., & Hjørne, N. (1973) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365517309084333 · Cited by 26
Plasma lipid levels and the diagnosis of coronary arteriosclerosis in England.
MILLS, G. L., & Wilkinson, P. A. (1966) · Heart · doi:10.1136/hrt.28.5.638 · Cited by 22
Plasma lipids and atherosclerosis.
Carlson, L. A. (1973) · Journal of Clinical Pathology · doi:10.1136/jcp.s1-5.1.43 · Cited by 13
Research works printed but not linked: 13
- Miller, 1973, J. Lab. clin. Med., 82, 876
- Goodman, 1973, J. Lipid Res., 52, 2646
- Insull, 1968, J. Lab. clin. Med., 72, 885
- Schreibman, 1973, Clin. Res., 21, 638
- P. Clifton-Bligh, N.E. Miller, P.J. Nestel, Clin. Sci. ((in the press)).
- Nikkilä, 1953, Scand. J. clin. Lab. Invest., 5
- Fredrickson, 1968, J. clin. Invest., 47, 2446, 10.1172/JCI105927 · DOI
- N.E. Miller, P.J. Nestel, Eur. J. clin. Invest. ((in the press)).
- Kannel, 1962, Geriatrics, 17, 675
- Murphy, 1962, J. Lab. clin. Med., 60, 86
- Kudchodkar, 1972, Clin. Res., 20, 944
- Jones, 1970, J. Lab. clin. Med., 75, 953
- Bondjers, 1974, Proc. Eur. Soc. clin. Invest., 8, 123
Cited by
Sorted by citations
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
The Metabolic Syndrome: Time for a Critical Appraisal
Kahn, R., Buse, J. B., Ferrannini, E., & Stern, M. P. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2289 · Cited by 2,400
Sanderson, E., Glymour, M. M., Holmes, M. V., Kang, H., Morrison, J., Munafò, M. R., Palmer, T., Schooling, C. M., Wallace, C., Zhao, Q., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-021-00092-5 · Cited by 2,229
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
Metadata
- Authors
- Miller, G. J., & Miller, N. E.
- Affiliations
- University Hospital Llandough (GB)
- Edinburgh Royal Infirmary (GB)
- ORCID
- Miller, G.J
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1975-01
- Volume
- 305
- Issue
- 7897
- Pages
- 16-19
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W1994967652
- Cited by
- 2,621
- References
- 59
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 9 · 2023: 7 · 2022: 15 · 2021: 17 · 2020: 24 · 2019: 18 · 2018: 18 · 2017: 17 · 2016: 29 · 2015: 29 · 2014: 22 · 2013: 32 · 2012: 26
- FWCI
- 157.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
- Keywords
- high-density lipoprotein, ischemic heart disease, atherosclerosis, cholesterol metabolism, hypercholesterolemia, hypertriglyceridemia, obesity, diabetes mellitus, sex differences, cardiovascular risk factors
- MeSH terms
- Arteries, Arteriosclerosis, Cholesterol, Coronary Disease, Denmark, Inuit, Female, Finland, Humans, Lipoproteins, HDL, Lipoproteins, LDL, Lipoproteins, VLDL, Liver, Male, Middle Aged, Sex Factors, Sweden, Triglycerides, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review